Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease (AFIRE)
Thank you Nikita for leading us through a discussion of the AFIRE trial.
Clinical Question:
In patients with atrial fibrillation and stable CAD >1 year after revascularization (or confirmed CAD on angiography not requiring revascularization), how does rivaroxaban monotherapy compare to rivaroxaban plus an antiplatelet agent in terms of efficacy and safety?
December 2019
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)
In this article, we review how prophylactic implantation of defibrillator decreases mortality in patients with advanced LV dysfunction following prior MI.
Congratulations to Dr. Sal Hernandez
Congratulations to our very own Dr. Salvador Hernandez for his recent important work on the prevalence of chronic comorbidities among people with Chagas Disease in Los Angeles. Dr. Hernandez works closely with the Center of Excellence for Chagas Disease (CECD)…
Morning report – High-Output Heart Failure
Thank you to Dr. Thetford for presenting a rare case of TIPS induced high output heart failure. A few take away points: HOHF is a rare form of heart failure caused by increased CO and decreased SVR Common causes: Obesity,…
September 2019
This month, we look at treatments for atrial fibrillation and rheumatoid arthritis. These treatments are commonly used for our patients at Olive View. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (ROCKET-AF) Therapies for Active Rheumatoid Arthritis after Methotrexate Failure